Valuation: Lead Data Inc.

Market Cap 539M 16.69M 14.59M 13.49M 12.38M 23.43M 1.61B 23.84M 161M 63.21M 785M 62.68M 61.31M 2.71B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.59M 15.38M 14.22M 13.05M 24.7M 1.7B 25.13M 170M 66.63M 828M 66.07M 64.62M 2.86B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%-0.28% 16.73M
+1.26%+6.06%+24.94%+9.79% 9.93B
-1.93%+18.24% - - 1.51B
-0.09%+1.13%+12.66%+2.43% 1.32B
+1.32%+3.34%+3.45%-10.46% 1.07B
+3.90%+11.38%+64.75%+37.29% 648M
+0.45%+8.28%-17.32%-55.30% 619M
-0.57%+5.08%+107.20%+160.65% 419M
-0.41%+3.90%-9.68%-12.81% 423M
+4.13%+19.24%-51.35%-80.26% 278M
Average -0.18%+3.90%+14.96%+5.67% 1.62B
Weighted average by Cap. +0.88%+5.59%+22.14%+8.07%

Financials

2024 2025
Net sales 15.47M 479K 419K 387K 355K 673K 46.17M 684K 4.62M 1.81M 22.55M 1.8M 1.76M 77.84M 111M 3.43M 3M 2.77M 2.54M 4.81M 330M 4.9M 33.06M 12.99M 161M 12.88M 12.6M 557M
Net income -134M -4.14M -3.62M -3.35M -3.07M -5.82M -399M -5.92M -39.96M -15.7M -195M -15.57M -15.22M -673M -44.02M -1.36M -1.19M -1.1M -1.01M -1.91M -131M -1.95M -13.15M -5.16M -64.17M -5.12M -5.01M -222M
Net Debt -16.95M -525K -459K -425K -390K -737K -50.61M -750K -5.06M -1.99M -24.72M -1.97M -1.93M -85.33M 29.12M 902K 789K 729K 669K 1.27M 86.93M 1.29M 8.7M 3.42M 42.45M 3.39M 3.31M 147M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock